First Spinal Fusion Patient Treated with New Luna® 360 Interbody Fusion System
February 9, 2015The first patient in the U.S. was treated with Benvenue Medical’s new Luna® 360 Interbody Fusion System, which is a first-in-class minimally invasive spinal fusion device designed to decrease or eliminate back pain.
More »
Orexigen Provides Progress Update on Mysimba European Marketing Authorization
February 9, 2015Orexigen provides an update on the European marketing authorization application for Mysimba™ for weight loss. The European Commission decision granting marketing authorization will be reviewed during a meeting of the Standing Committee in March.
More »
CoLucid Pharmaceuticals Appoints Matthew Dallas as Chief Financial Officer and Treasurer
February 9, 2015CoLucid Pharmaceuticals appoints Matthew Dallas as chief financial officer and treasurer, simultaneously announced with the retirement of Tim C. Gupton, CPA, CoLucid's CFO since its inception.
More »